Close Menu

NEW YORK – Roche said Thursday that its diagnostics division revenues grew 2 percent  percent year over year, or 9 percent on a constant exchange rate, in the first nine months of 2020, driven mainly by COVID-19 testing.

For the nine months of 2020, the Basel, Switzerland-based company's total revenues declined 5 percent to CHF 43.98 billion ($48.12 billion) from CHF 46.07 billion during the same period in 2019. At CER, total revenues for the period rose 1 percent.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.